pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
SKL-20540
Cognitive Impairment Associated With Schizophrenia (CIAS)
SK Life Science Inc
0
catalysts
Phase 1
SKL-24741
Epilepsy
SK Life Science Inc
0
catalysts
Phase 1
SL-325
Crohn's Disease (Regional Enteritis)
$STTK
Shattuck Labs, Inc.
0
catalysts
Phase 2
← prev
page 133 of 231
next →
131
Pain
89
Neurology
1
SL-701
Recurrent Glioblastoma Multiforme (GBM)
Stemline Therapeutics Inc
0
catalysts
Preclinical
SLATEV-3
Unspecified Cancer
Nexoplex Bio LLC
0
catalysts
Preclinical
SLEN-47
Solid Tumor
Gencirq Inc
0
catalysts
Phase 2
SLIF-06
Hypertrophic Scars
Scarless Laboratories Inc
0
catalysts
Phase 1
SLV-213
Coronavirus Disease 2019 (COVID-19)
Selva Therapeutics Inc
0
catalysts
Preclinical
SM-06
Neuromyelitis Optica (Devic's Syndrome)
SinoMab Bioscience Ltd
0
catalysts
Phase 2
SMART-101
Refractory Acute Myeloid Leukemia
Smart Immune SAS
0
catalysts
Preclinical
SMB-603
Traumatic Brain Injury
Symbinas Pharmaceuticals Inc
0
catalysts
Preclinical
SMB-604
Traumatic Brain Injury
Symbinas Pharmaceuticals Inc
0
catalysts
SMOFLIPID
SMOFLIPID (SMOFLIPID)
FRESENIUS KABI USA
0
catalysts
Phase 2
SMP-3124
Anal Cancer
Sumitomo Pharma Co Ltd
0
catalysts
Preclinical
SMTM-01
Duchenne Muscular Dystrophy
Cellular Intelligence Inc
0
catalysts
Preclinical
SN-40X
Type 2 Diabetes
Senseion Therapeutics Inc
0
catalysts
Phase 2
SN-514
Burns
SERDA Therapeutics BV
0
catalysts
Phase 1
SNA-11
Synxyrin
Treatment Resistant Depression
SyneuRx International (Taiwan) Corp
0
catalysts
Phase 2
SNB-011
Pentarlandir
Coronavirus Disease 2019 (COVID-19)
SyneuRx International (Taiwan) Corp
0
catalysts
Preclinical
SND-006
Inflammatory Bowel Disease
Jiangsu Sinorda Biomedicine Co Ltd
0
catalysts
Phase 2
SND-51
Dementia
SyneuRx International (Taiwan) Corp
0
catalysts
Phase 1
SNG-1153
Hepatocellular Carcinoma
Shenogen Pharma Group Ltd
0
catalysts
Phase 3
SNG-12
Depression
SyneuRx International (Taiwan) Corp
0
catalysts
Preclinical
SNH-110
Unspecified Cancer
ScinnoHub Pharmaceutical Co Ltd
0
catalysts
Phase 2
SNIPR-001
Escherichia coli Infections
SNIPR Biome ApS
0
catalysts
Phase 1
SNK-02
Angiosarcoma
NKGen Biotech Inc
0
catalysts
Phase 2
SNP-610
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Sinew Pharma Inc
0
catalysts
Phase 1
SNP-630
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Sinew Pharma Inc
0
catalysts
Phase 2
SNS-812
Coronavirus Disease 2019 (COVID-19)
Oneness Biotech Co Ltd
0
catalysts
Preclinical
SNV-401
Angelman Syndrome
Senovia Biosciences
0
catalysts
